Main
>
ONCOLOGY (**)
>
MyeloDysplastic Syndromes ***
>
Treatment
>
USA. O. Decitabine+Cedazuridine
>
(*) CA/USA Approval: 2020. 07.07.
(*) CA/USA Approval: 2020. 07.07.'s products
This section has no products